Depleting the 19S proteasome regulatory PSMD1 subunit as a cancer therapy strategy.
Julia AdlerRoni OrenYosef ShaulPublished in: Cancer medicine (2023)
Our results suggest that reducing the 26S/20S ratio might be a valuable strategy for treating drug-resistant aggressive types of cancers.